Biotech Companies

797 companies | Drug discovery and development companies

#	COMPANY	THERAPEUTIC AREAS	STAGE
1.	180 Collagen (NZ) Limited Te Awamutu, New Zealand		Commercial	VIEW
2.	4 Animals AlsterScience GmbH Hamburg, Germany	Immunology Oncology Infectious Disease	Preclinical	VIEW
3.	4D Pharma plc Leeds, United Kingdom	Oncology Immunology Gastroenterology	Preclinical to Phase II (at time of administration)	VIEW
4.	AC Immune SA Lausanne, Switzerland		Phase 2	VIEW
5.	ACI Limited Dhaka, Bangladesh		Commercial	VIEW
6.	ADARx Pharmaceuticals San Diego, USA	Neuroscience Immunology Oncology	Phase 3	VIEW
7.	ADMA Biologics, Inc. Ramsey, New Jersey, United States		Commercial + Preclinical	VIEW
8.	AGS Therapeutics Paris, France	Ophthalmology Immunology Infectious Disease+2	Preclinical	VIEW
9.	ARCS Australia North Sydney, Australia		-	VIEW
10.	ASKA Pharmaceutical Co., Ltd. Tokyo, Japan	Gastroenterology	Commercial	VIEW
11.	Aardvark Therapeutics San Diego, USA	Rare Diseases Metabolic	Phase 3	VIEW
12.	AbCellera Vancouver, Canada	Metabolic Immunology Oncology	Phase 2	VIEW
13.	Abbisko Therapeutics Shanghai, China	Oncology	Phase 3	VIEW
14.	Abcuro, Inc. Newton, Massachusetts, USA	Immunology Oncology Rare Diseases	Phase 2/3	VIEW
15.	Abdera Therapeutics South San Francisco, USA / Vancouver, Canada	Oncology	Phase 1	VIEW
16.	Abeona Therapeutics Inc. Cleveland, Ohio, USA	Rare Diseases Ophthalmology Dermatology	Commercial	VIEW
17.	Abiogen Pharma S.p.A. Pisa, Italy	Respiratory Metabolic Dermatology+1	Commercial	VIEW
18.	Abivax Paris, France	Immunology Gastroenterology	Phase 3	VIEW
19.	Acadia Pharmaceuticals Inc. San Diego, USA	Neuroscience Rare Diseases	Commercial	VIEW
20.	Acelot South San Francisco, California, USA	Metabolic Oncology	Preclinical	VIEW
21.	Acrux Melbourne, Australia	Dermatology Metabolic	Commercial	VIEW
22.	Actinogen Medical Sydney, Australia		Phase 2/3	VIEW
23.	AdvantiGen Biosciences Madison, WI, United States	Oncology Immunology	Discovery	VIEW
24.	Advanz Pharma London, United Kingdom	Gastroenterology Metabolic Oncology+2	Commercial\|Phase 2\|Phase 3	VIEW
25.	Aegros Macquarie Park, Australia	Infectious Disease Immunology	Clinical	VIEW
26.	Aerogen Pharma San Mateo, USA / Galway, Ireland	Respiratory	Phase 3	VIEW
27.	Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA)	Oncology Immunology Infectious Disease	Clinical	VIEW
28.	Agios Pharmaceuticals Cambridge, USA	Rare Diseases Hematology Metabolic	Commercial	VIEW
29.	Agomab Therapeutics Antwerp, Belgium	Gastroenterology Rare Diseases	Phase 2	VIEW
30.	Ajou University Suwon, South Korea	Oncology Immunology Neuroscience+2	Phase 3	VIEW
31.	Akebia Therapeutics Cambridge, USA	Rare Diseases	Commercial	VIEW
32.	Akribes Biomedical Vienna, Austria	Dermatology	Preclinical	VIEW
33.	Al-Razi Pharma Industries Dammam, Saudi Arabia		Commercial	VIEW
34.	Alembic Pharmaceuticals Limited Vadodara, India	Cardiovascular Dermatology Oncology+3	Commercial	VIEW
35.	Alkermes plc Dublin, Ireland	Neuroscience	Commercial	VIEW
36.	Alkeus Pharmaceuticals Cambridge, USA	Ophthalmology Rare Diseases	Phase 3	VIEW
37.	Allergy Therapeutics Worthing, United Kingdom		Phase 3 and Phase 1/2	VIEW
38.	Allygen Biosciences Shanghai, China	Oncology Immunology	Preclinical	VIEW
39.	Alnylam Pharmaceuticals Cambridge, USA	Infectious Disease	Commercial	VIEW
40.	AltruBio, Inc. San Francisco, USA	Immunology	Phase 2	VIEW
41.	Alumis Inc. South San Francisco, USA	Immunology Dermatology Neuroscience+1	Phase 3	VIEW
42.	Amarin Corporation plc Dublin, Ireland	Cardiovascular	Commercial	VIEW
43.	Ampersand Biomedicines Boston, MA, USA	Metabolic	Preclinical	VIEW
44.	Amylyx Pharmaceuticals Cambridge, USA	Rare Diseases	Phase 3	VIEW
45.	Anavex Life Sciences Corp. New York, United States	Oncology	Phase 2\|Phase 3	VIEW
46.	Angelini Pharma Rome, Italy	Neuroscience Infectious Disease	Phase 3	VIEW
47.	Anocca AB Södertälje, Sweden	Oncology Immunology Infectious Disease	Phase 1	VIEW
48.	Antaria Limited Perth, Australia		-	VIEW
49.	Anyea Therapeutics Co., Ltd. Shanghai, China	Neuroscience	Discovery	VIEW
50.	Apellis Pharmaceuticals, Inc. Waltham, Massachusetts, USA	Ophthalmology Rare Diseases Immunology	Commercial	VIEW
51.	ApicHope Pharmaceutical Group Co., Ltd. Guangzhou, China	Metabolic Infectious Disease	Phase 3	VIEW
52.	Apogee Therapeutics, Inc. Waltham, USA	Dermatology Respiratory	Phase 2	VIEW
53.	Apotex Inc. Toronto, Canada	Cardiovascular Oncology Neuroscience+1	Commercial	VIEW
54.	Appili Therapeutics Inc. Halifax, Canada	Infectious Disease	Commercial	VIEW
55.	Aprogen Seongnam-si, South Korea	Oncology Immunology	Commercial	VIEW
56.	Apsen Farmacêutica São Paulo, Brazil	Neuroscience Gastroenterology	Phase 3	VIEW
57.	Aquinas Companies, LLC (Fannin Innovation Studio) Houston, Texas, USA	Oncology Infectious Disease Cardiovascular+2	Phase 2	VIEW
58.	Araceli Biosciences Tigard, Oregon, United States		Seed	VIEW
59.	Aramis Biotechnologies Quebec City, Canada	Infectious Disease	Phase 1/2	VIEW
60.	Arcera Life Sciences Abu Dhabi, United Arab Emirates	Neuroscience Cardiovascular Gastroenterology+1	Commercial	VIEW
61.	Arcus Biosciences Hayward, United States	Oncology Immunology	Phase 3	VIEW
62.	Arcutis Biotherapeutics Westlake Village, California, United States	Dermatology	Commercial & Phase 1/2	VIEW
63.	Ardelyx Waltham, Massachusetts, USA	Gastroenterology	Commercial	VIEW
64.	Argo Biopharma Shanghai, China	Cardiovascular Metabolic Hematology+2	Phase 2	VIEW
65.	Aristo Pharmaceuticals Private Limited Mumbai, India	Gastroenterology Respiratory	Commercial	VIEW
66.	Aristopharma Ltd. Dhaka, Bangladesh	Oncology Cardiovascular	Commercial	VIEW
67.	Ark Biosciences Shanghai, China	Respiratory Infectious Disease Neuroscience	Commercial	VIEW
68.	Arrivo BioVentures Morrisville, USA	Neuroscience Gastroenterology	Phase 2	VIEW
69.	Arrowhead Pharmaceuticals Pasadena, California, United States	Metabolic	Commercial \| Phase 3 \| Phase 2 \| Phase 1	VIEW
70.	Artica Therapeutics Leiden, Netherlands	Immunology	Preclinical	VIEW
71.	Artificial Axon Labs Cambridge, Massachusetts, USA	Neuroscience	Discovery	VIEW
72.	Arvinas, Inc. New Haven, Connecticut, United States	Oncology Neuroscience	Phase 1-3	VIEW
73.	Ascentage Pharma Suzhou, China	Oncology	Commercial	VIEW
74.	Asclepii Cleveland, USA		Commercial	VIEW
75.	Asha Cellulose (I) Pvt. Ltd. Mumbai, India		-	VIEW
76.	Asimetra Biotech Solutions Girona, Spain		-	VIEW
77.	AskGene Camarillo, California, United States	Oncology Immunology Ophthalmology	Phase 3	VIEW
78.	Asklepion Pharmaceuticals, LLC Baltimore, Maryland, USA		Phase 3	VIEW
79.	Asklepios BioPharmaceutical Research Triangle Park, North Carolina, USA	Metabolic	Phase 1\|Phase 2\|Preclinical	VIEW
80.	Aspen Global Incorporated Grand Bay, Mauritius	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
81.	Assertio Holdings, Inc. Lake Forest, USA	Neuroscience Immunology Oncology	Commercial	VIEW
82.	Assistance Publique - Hôpitaux de Marseille (AP-HM) Marseille, France	Rare Diseases Oncology	Clinical	VIEW
83.	AtaiBeckley (formerly ATAI Life Sciences) Berlin, Germany (original); U.S. redomiciliation completed December 30, 2025		Phase 2	VIEW
84.	Atara Biotherapeutics, Inc. Thousand Oaks, California, USA	Oncology Immunology	Clinical	VIEW
85.	Atea Pharmaceuticals Boston, Massachusetts, United States		Phase 3 (HCV), Phase 1 planned (HEV)	VIEW
86.	Aucta Pharmaceuticals Basking Ridge, New Jersey, USA	Dermatology Ophthalmology Respiratory	Commercial \| Phase 2 \| Preclinical	VIEW
87.	Autobahn Therapeutics San Diego, USA	Neuroscience	Phase 2	VIEW
88.	Autolus Therapeutics London, United Kingdom	Oncology Immunology Rare Diseases	Commercial + Phase 1/2	VIEW
89.	Avalon Pharma (Middle East Pharmaceutical Industries Co.) Riyadh, Saudi Arabia	Dermatology Respiratory Cardiovascular+3	Commercial	VIEW
90.	Avenzo Therapeutics San Diego, USA	Oncology	Phase 2	VIEW
91.	Axalbion Lausanne, Switzerland	Respiratory Ophthalmology Neuroscience	Phase 2	VIEW
92.	Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) G. Brotzu Cagliari, Italy	Oncology Hematology Metabolic	Commercial	VIEW
93.	AziraMed Strategy Waterford, Ireland		-	VIEW
94.	Azurity Pharmaceuticals Woburn, USA	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
95.	B.Grimm Pharma Bangkok, Thailand	Cardiovascular Gastroenterology Infectious Disease+1	Commercial	VIEW
96.	BGI Group Shenzhen, China	Oncology Rare Diseases Infectious Disease	Commercial	VIEW
97.	BIAL São Mamede do Coronado, Trofa, Porto, Portugal	Cardiovascular Rare Diseases	Phase 2 (lead candidate)	VIEW
98.	BIKEN Foundation Suita, Japan	Infectious Disease	Commercial	VIEW
99.	BIOCAD Saint Petersburg, Russia	Oncology Immunology Infectious Disease	Commercial	VIEW
100.	BIOVIIIx Naples, Italy	Rare Diseases Hematology Oncology	Discovery	VIEW
101.	BRIM Biotechnology, Inc. Taipei, Taiwan	Ophthalmology Rare Diseases	Phase 3	VIEW
102.	Basilea Pharmaceutica Allschwil, Switzerland	Infectious Disease	Phase 3	VIEW
103.	BeBioSol India		-	VIEW
104.	BeOne Medicines (formerly BeiGene) Cambridge, Massachusetts, United States (corporate); Basel, Switzerland (post-redomiciliation May 2025)	Oncology	Phase 1-3 and Commercial	VIEW
105.	Beijing Sungen Biomedical Technology Co., Ltd. Beijing, China	Cardiovascular Oncology Infectious Disease	Phase 2	VIEW
106.	Belenos Biosciences New York, NY, USA	Immunology Respiratory Dermatology	Phase 1/2	VIEW
107.	Belief BioMed Shanghai, China	Rare Diseases Hematology Neuroscience+1	Commercial	VIEW
108.	BenevolentAI London, United Kingdom	Oncology Immunology Neuroscience+3	Phase 1\|Phase 2\|Preclinical	VIEW
109.	Benitec Biopharma Inc. Hayward, California, USA	Infectious Disease Oncology	Phase 1b/2a (BB-301), Preclinical (other programs)	VIEW
110.	Beren Therapeutics P.B.C. Thousand Oaks, USA	Rare Diseases	Phase 3	VIEW
111.	Berg Health Framingham, Massachusetts, USA	Oncology Neuroscience Rare Diseases	Phase 1/2	VIEW
112.	Besins Healthcare Monaco, Monaco	Metabolic	Commercial	VIEW
113.	Bharat Biotech Hyderabad, India	Infectious Disease Oncology	Commercial	VIEW
114.	Bharat Serums and Vaccines Limited (BSV Group) Navi Mumbai, India		Commercial	VIEW
115.	Bicycle Therapeutics plc Cambridge, United Kingdom	Oncology	Phase 2	VIEW
116.	Bio Usawa Inc. San Mateo, USA / Kigali, Rwanda	Oncology Infectious Disease Ophthalmology	Preclinical	VIEW
117.	Bio-Gene Technology Limited Shatin, Hong Kong		-	VIEW
118.	BioCardia, Inc. Sunnyvale, California, USA	Cardiovascular Respiratory	Phase 3	VIEW
119.	BioData Solutions Lawrence, Kansas, USA	Oncology Rare Diseases	-	VIEW
120.	BioInvent International AB Lund, Sweden	Oncology	Phase 2	VIEW
121.	BioLineRx Ltd. Modiin, Israel	Oncology Rare Diseases	Commercial	VIEW
122.	BioMarin Pharmaceutical Inc. San Rafael, USA	Hematology Metabolic Cardiovascular	Commercial	VIEW
123.	BioMed Valley Discoveries Kansas City, Missouri, USA	Oncology Immunology Rare Diseases+1	Clinical (Phase 1-2)	VIEW
124.	BioNTech Mainz, Germany	Oncology Immunology Infectious Disease	Phase 1-3	VIEW
125.	BioNTech SE Mainz, Germany	Oncology Infectious Disease Rare Diseases	Commercial	VIEW
126.	BioPharma Network Milan, Italy		-	VIEW
127.	Biocase Brasil Itajaí, Brazil		Preclinical	VIEW
128.	Biohaven Ltd. New Haven, USA	Neuroscience Immunology Oncology+1	Phase 3	VIEW
129.	Biological E. Limited Hyderabad, India	Infectious Disease Gastroenterology	Commercial	VIEW
130.	Biomea Fusion San Carlos, USA	Metabolic Oncology	Phase 2	VIEW
131.	Bionexus (주식회사 바이오넥서스) Suwon, South Korea		Discovery	VIEW
132.	Bioreaction.tech (Bioreaction.tech Kft.) Debrecen, Hungary		Seed	VIEW
133.	BioscienceLA Culver City, USA		-	VIEW
134.	Biotest AG Dreieich (Frankfurt), Germany	Hematology	Phase 3/Commercial	VIEW
135.	Biotest AG Dreieich, Germany	Hematology	Phase 2\|Phase 3\|Commercial	VIEW
136.	Biovet AD Peshtera, Bulgaria		Commercial	VIEW
137.	Blau Farmacêutica S.A. Cotia, Brazil	Immunology Hematology Oncology+1	Commercial	VIEW
138.	BlossomHill Therapeutics San Diego, USA	Oncology Immunology	Phase 1	VIEW
139.	BlueRock Therapeutics Cambridge, USA	Neuroscience Cardiovascular Ophthalmology+1	Phase 3	VIEW
140.	Blueprint Medicines Cambridge, USA	Oncology Hematology Immunology+1	Commercial	VIEW
141.	Boostimmune Seoul, South Korea	Oncology Immunology	Preclinical	VIEW
142.	Bota Biosciences Hangzhou, China (International HQ in Lafayette, CA, USA)		Commercial	VIEW
143.	BrainXell, Inc. Madison, WI, USA	Neuroscience Rare Diseases	Preclinical	VIEW
144.	BridgeBio Oncology Therapeutics, Inc. South San Francisco, USA	Oncology	Phase 1	VIEW
145.	BunyaVax Lelystad, Netherlands	Infectious Disease Oncology	Phase 1	VIEW
146.	Burke Therapeutics, LLC Hot Springs, Arkansas, USA	Dermatology	Discovery	VIEW
147.	C-Ray Therapeutics Chengdu, China	Oncology	Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
148.	CAMP4 Therapeutics Cambridge, USA	Rare Diseases	Phase 1	VIEW
149.	CDR-Life Schlieren, Zurich, Switzerland	Oncology Immunology Ophthalmology	Phase 1	VIEW
150.	CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan	Oncology Neuroscience Infectious Disease	Preclinical	VIEW
151.	CEPI Oslo, Norway	Infectious Disease	Commercial	VIEW
152.	CF PharmTech, Inc. Suzhou, China	Respiratory	Commercial	VIEW
153.	CG Oncology, Inc. Irvine, USA	Oncology	Phase 3	VIEW
154.	CHA University Seongnam, South Korea		Discovery	VIEW
155.	CHA University Seongnam-si, South Korea		Discovery	VIEW
156.	CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland	Oncology Immunology Neuroscience+2	Phase 3	VIEW
157.	CS Pharmaceuticals Limited London, United Kingdom	Ophthalmology Rare Diseases	Phase 2	VIEW
158.	CSM Consulting, LLC United States	Cell Therapy Gene Therapy	-	VIEW
159.	CURE5 Foundation New York, USA	Rare Diseases Neuroscience	Discovery	VIEW
160.	Cabaletta Bio, Inc. Philadelphia, USA	Immunology Neuroscience Dermatology	Phase 1/2	VIEW
161.	Cal Crop USA USA		-	VIEW
162.	Caldera Therapeutics Cambridge, USA	Immunology Gastroenterology	Phase 1	VIEW
163.	Calico Life Sciences South San Francisco, United States	Oncology Neuroscience Immunology	Phase 2	VIEW
164.	Calidi Biotherapeutics San Diego, USA	Oncology	Phase 2	VIEW
165.	Calliditas Therapeutics Stockholm, Sweden	Rare Diseases	Commercial	VIEW
166.	Calluna Pharma Oslo, Norway	Immunology	Phase 2	VIEW
167.	Camurus AB Lund, Sweden	Neuroscience Rare Diseases Metabolic+1	Commercial	VIEW
168.	CanariaBio Inc. Seoul, South Korea	Oncology	Phase 3	VIEW
169.	Cancer Research UK London, United Kingdom	Oncology	Phase 2	VIEW
170.	Cantargia AB Lund, Sweden	Oncology Immunology	Phase 1 - Phase 2	VIEW
171.	Captor Therapeutics Wroclaw, Poland	Oncology Immunology	Preclinical	VIEW
172.	Cardurion Pharmaceuticals Burlington, United States	Cardiovascular	Phase 2	VIEW
173.	Caritas Healthcare Private Limited Ahmedabad, India	Oncology	Commercial	VIEW
174.	Carrick Therapeutics Dublin, Ireland	Oncology	Phase 2	VIEW
175.	Carroll Bio-Consulting Boston, USA	Oncology Rare Diseases	Commercial	VIEW
176.	Cell-Tx Seoul, South Korea	Neuroscience Oncology Ophthalmology	Preclinical	VIEW
177.	Cellectis Paris, France	Oncology Immunology Rare Diseases	Phase 2	VIEW
178.	Celon Pharma Łomianki, Poland	Neuroscience Oncology Immunology+1	Phase 3	VIEW
179.	Celularity Inc Florham Park, New Jersey, USA	Oncology	Phase 1/2 and Phase 2	VIEW
180.	Centaur Laboratories Private Limited Mumbai, India		-	VIEW
181.	Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong	Neuroscience Rare Diseases	Preclinical	VIEW
182.	Center of Molecular Immunology (CIM) Havana, Cuba	Oncology Immunology	Commercial	VIEW
183.	Centrexion Therapeutics Boston, Massachusetts, United States	Immunology	Phase 1-3	VIEW
184.	Cerevel Therapeutics Cambridge, Massachusetts, USA		Phase 1-3	VIEW
185.	Chan Zuckerberg Biohub Network San Francisco, USA	Infectious Disease Rare Diseases Immunology	Discovery	VIEW
186.	Changchun GeneScience Pharmaceutical Co., Ltd. Changchun, China	Metabolic Oncology Immunology+1	Clinical	VIEW
187.	Chengdu Kanghong Pharmaceutical Group Chengdu, China	Ophthalmology Neuroscience Oncology	Commercial	VIEW
188.	Chiba University Chiba, Japan	Oncology Immunology Rare Diseases+3	Phase 2	VIEW
189.	China Medical System Holdings Ltd. Shenzhen, China	Dermatology Gastroenterology Ophthalmology+1	Commercial	VIEW
190.	China Medical University Hospital (CMUH) Taichung, Taiwan	Oncology Neuroscience Cardiovascular+2	Phase 2	VIEW
191.	Chongqing PegBio Biotechnology Co., Ltd. Chongqing, China	Gastroenterology Hematology Oncology	Phase 3	VIEW
192.	Choose Life Biotech SA Bellinzona, Switzerland	Immunology Infectious Disease Oncology	Preclinical	VIEW
193.	Chosun University Hospital Gwangju, South Korea	Oncology Metabolic Gastroenterology	Discovery	VIEW
194.	Chung-Ang University Seoul, South Korea	Oncology Cardiovascular Immunology+2	Phase 3	VIEW
195.	Cincinnati Children's Hospital Medical Center Cincinnati, USA	Oncology Immunology Rare Diseases+4	Commercial	VIEW
196.	Circio Holding ASA Lysaker, Norway	Oncology Immunology Gene Therapy	Phase 1/2	VIEW
197.	City of Hope Duarte, California, USA	Oncology Hematology Rare Diseases	Commercial	VIEW
198.	Clasp Therapeutics Rockville, Maryland, USA	Oncology	Phase 1	VIEW
199.	Clinny Bio		-	VIEW
200.	Clinuvel Pharmaceuticals Melbourne, Australia	Rare Diseases Dermatology Neuroscience	Commercial	VIEW
201.	Codexis, Inc. Redwood City, California, USA	Rare Diseases Metabolic	Commercial	VIEW
202.	Coherus BioSciences, Inc. Redwood City, USA	Oncology	Commercial	VIEW
203.	College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences (SRIPMS) Coimbatore, India		-	VIEW
204.	Comanche Biopharma Corp. Concord, USA		Phase 1	VIEW
205.	Complement Therapeutics United Kingdom (University of Manchester spinout, with facilities in UK and Germany)	Ophthalmology	Phase I/II	VIEW
206.	Constructor Group Schaffhausen, Switzerland	Oncology Infectious Disease Neuroscience	Preclinical	VIEW
207.	Corcept Therapeutics Redwood City, USA	Metabolic Oncology Neuroscience	Commercial	VIEW
208.	Corline Biomedical AB Uppsala, Sweden	Metabolic Cardiovascular Neuroscience	Phase 2	VIEW
209.	Corona Remedies Limited Ahmedabad, India	Cardiovascular Gastroenterology Respiratory	Commercial	VIEW
210.	Cosmo Pharmaceuticals N.V. Dublin, Ireland	Gastroenterology Dermatology Infectious Disease	Commercial	VIEW
211.	Coya Therapeutics, Inc. Houston, USA	Immunology	Phase 2	VIEW
212.	Createrna Science and Technology Wuhan, China	Cardiovascular Respiratory Immunology	Phase 2	VIEW
213.	Crescent Biopharma, Inc. Waltham, USA	Oncology	Phase 1/2	VIEW
214.	Crixmor LLC Malvern, Pennsylvania, USA	Immunology Gastroenterology Oncology	Discovery	VIEW
215.	CryoLife Scientific LLP Thane, India		Discovery	VIEW
216.	Cugene Inc. Waltham, USA	Oncology Immunology	Phase 1	VIEW
217.	Cullinan Therapeutics Cambridge, USA	Oncology Immunology	Phase 3	VIEW
218.	CuraTeQ Biologics Hyderabad, India	Oncology Immunology Metabolic	Commercial	VIEW
219.	CuraVac Rixensart, Belgium	Immunology	Phase 1B (completed) \| Phase 2 (in preparation)	VIEW
220.	Curadev Pharma Pvt Ltd Noida, India	Oncology Immunology Metabolic	Phase 1	VIEW
221.	Curaleaf Holdings, Inc. Wakefield, Massachusetts, USA		Commercial	VIEW
222.	Curasight Copenhagen, Denmark	Oncology	Phase 1-2 Clinical	VIEW
223.	Curatis Liestal, Switzerland	Oncology Neuroscience Respiratory+1	Phase 3	VIEW
224.	Curative Biotechnology Inc Boca Raton, Florida, USA	Infectious Disease	Pre-Clinical\|IND-Enabling Studies	VIEW
225.	CureVac Tübingen, Germany	Oncology Infectious Disease Rare Diseases	Phase 2	VIEW
226.	Curis, Inc. Lexington, USA	Oncology	Phase 1/2	VIEW
227.	Curocell Inc. Daejeon, South Korea	Oncology Hematology	Commercial	VIEW
228.	CytoAgents Pittsburgh, USA	Oncology Immunology Infectious Disease+1	Phase 2	VIEW
229.	CytoDyn Inc Vancouver, Washington	Oncology Immunology	Phase 2 clinical	VIEW
230.	CytoImmune Therapeutics Duarte, USA	Oncology Hematology Immunology	Phase 1	VIEW
231.	CytoSen Therapeutics Orlando (Winter Springs), Florida, USA	Oncology Cell Therapy Immunology	Phase 2	VIEW
232.	CytoTools AG Heidelberg, Germany	Dermatology Cardiovascular Oncology	Phase 3	VIEW
233.	CytoVac Hørsholm, Denmark	Oncology	Phase 2	VIEW
234.	Cytochroma Edinburgh, United Kingdom	Cardiovascular Rare Diseases	Discovery	VIEW
235.	Cytocom, Inc. Fort Collins, Colorado, USA	Oncology Infectious Disease Hematology+1	Phase 2/Phase 3	VIEW
236.	CytomX Therapeutics, Inc. South San Francisco, California, United States	Oncology	Phase 1 (clinical), Preclinical (discovery collaborations)	VIEW
237.	Cytomos Edinburgh, United Kingdom	Cell Therapy Gene Therapy Oncology	Commercial	VIEW
238.	Cytonics Corporation Jupiter, Florida, USA	Immunology	Phase 2	VIEW
239.	Cytonus Therapeutics Carlsbad, California, United States	Oncology Immunology Infectious Disease+1	Phase 1	VIEW
240.	Cytorex Biosciences Weston, Florida, USA	Oncology Metabolic Infectious Disease	Preclinical	VIEW
241.	Cytovation Bergen, Norway	Oncology Rare Diseases	Phase I/II - Phase II	VIEW
242.	Cytovia Therapeutics Aventura, Florida, USA	Oncology Immunology	Phase 1/2	VIEW
243.	Cyxone Malmö, Sweden	Immunology Neuroscience	Phase 2	VIEW
244.	D&D Pharmatech Seongnam-si, South Korea		Phase 2	VIEW
245.	DBV Technologies Châtillon, France	Immunology	Phase 3	VIEW
246.	Dankook University Yongin and Cheonan, South Korea	Oncology Neuroscience Rare Diseases+1	Phase 2	VIEW
247.	Dartmouth College Hanover, USA	Oncology Immunology Neuroscience+2	Phase 3	VIEW
248.	Day One Biopharmaceuticals Brisbane, United States	Oncology Rare Diseases	Commercial	VIEW
249.	Debiopharm Lausanne, Switzerland	Oncology Rare Diseases	Phase 1, Phase 2, Phase 3	VIEW
250.	Dendreon Pharmaceuticals Seal Beach, USA	Oncology	Commercial	VIEW
251.	DevaCell, Inc. San Diego, USA	Oncology Infectious Disease Gene Therapy	Preclinical	VIEW
252.	Development Center for Biotechnology (DCB) Taipei, Taiwan	Oncology Immunology Infectious Disease	Preclinical	VIEW
253.	Dexa Medica Tangerang, Indonesia	Oncology	Commercial	VIEW
254.	Dexcel Pharma Or Akiva, Israel	Oncology Cardiovascular Neuroscience+2	Commercial	VIEW
255.	DifGen Pharmaceuticals Miramar, USA	Ophthalmology Neuroscience	Commercial	VIEW
256.	Differential Bio Munich, Germany		Commercial	VIEW
257.	Dizal Pharmaceutical Shanghai, China	Oncology Immunology	Commercial	VIEW
258.	Dolomite TX		-	VIEW
259.	Dolor Therapeutics, Inc. Chicago, USA	Immunology	Preclinical	VIEW
260.	Dompé Farmaceutici Milan, Italy	Ophthalmology Rare Diseases Metabolic+2	Commercial	VIEW
261.	Drugs for Neglected Diseases initiative (DNDi) Geneva, Switzerland	Infectious Disease	Commercial	VIEW
262.	Duality Biologics Shanghai, China	Oncology Immunology	Phase 3	VIEW
263.	Duopharma Biotech Berhad Kuala Lumpur, Malaysia	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
264.	Dyne Therapeutics, Inc. Waltham, Massachusetts, USA		Phase 1/2, Phase 3	VIEW
265.	E-Flask Seongnam, South Korea	Neuroscience Oncology	Phase 1	VIEW
266.	EEE Pharma Maharashtra, India	Infectious Disease Immunology Cardiovascular+1	Commercial	VIEW
267.	EIPICO 10th of Ramadan City, Egypt	Oncology Ophthalmology Cardiovascular+1	Phase 3	VIEW
268.	ETH Zürich Zurich, Switzerland	Oncology Immunology Neuroscience+4	Discovery	VIEW
269.	EUBREAST Esslingen, Germany	Oncology	Phase 3	VIEW
270.	Edge Therapeutics, Inc. Princeton, New Jersey, USA	Oncology Infectious Disease	Phase 3	VIEW
271.	Edgewise Therapeutics Boulder, USA		Phase 2	VIEW
272.	Efroze Chemical Industries (Pvt.) Ltd. Karachi, Pakistan	Cardiovascular Gastroenterology	Commercial	VIEW
273.	Eledon Pharmaceuticals Irvine, USA	Immunology	Phase 2	VIEW
274.	Elevar Therapeutics Fort Lee, USA	Oncology	Phase 3	VIEW
275.	Eleven Therapeutics Cambridge, United Kingdom	Infectious Disease	Discovery	VIEW
276.	Elixiron Immunotherapeutics Taipei, Taiwan	Oncology Immunology	Phase 2	VIEW
277.	Ellipses Pharma London, United Kingdom	Oncology	Phase 1/2	VIEW
278.	Emergent BioSolutions Gaithersburg, Maryland, USA	Infectious Disease	Commercial	VIEW
279.	Empresa de Laboratorios AICA La Lisa, Havana, Cuba	Infectious Disease Oncology	Commercial	VIEW
280.	Enanta Pharmaceuticals, Inc. Watertown, Massachusetts, USA	Immunology	Phase 1-2 clinical	VIEW
281.	Eneapharm Labège, France	Gastroenterology Rare Diseases	Clinical	VIEW
282.	Enlivex Therapeutics Ltd. Ness Ziona, Israel	Immunology Oncology Infectious Disease	Phase 2	VIEW
283.	Ensem Therapeutics Waltham, MA, USA	Oncology	Phase 1/2	VIEW
284.	Entact Bio Watertown, USA	Oncology Immunology Rare Diseases	Preclinical	VIEW
285.	Epione Medicine ApS Hvidovre, Denmark		-	VIEW
286.	Eris Therapeutics Limited Ahmedabad, India	Cardiovascular Gastroenterology Dermatology	Commercial	VIEW
287.	Estetra SRL Liège, Belgium	Oncology	Commercial	VIEW
288.	Ethypharm Saint-Cloud, France	Neuroscience	Commercial	VIEW
289.	Eugia US LLC East Windsor, New Jersey, USA	Oncology Respiratory Hematology+2	Commercial	VIEW
290.	EurimPharm Arzneimittel GmbH Saaldorf-Surheim, Germany	Oncology Immunology Neuroscience+2	Commercial	VIEW
291.	Everest Medicines Shanghai, China	Immunology Oncology Cardiovascular+1	Commercial	VIEW
292.	Evopoint Biosciences Suzhou, China	Oncology Infectious Disease Immunology	Commercial (NDA Stage)	VIEW
293.	Evotec SE Hamburg, Germany	Oncology Neuroscience Infectious Disease+1	Commercial	VIEW
294.	Exelixis Alameda, USA	Oncology	Commercial	VIEW
295.	Exeltis Florham Park, USA (Global HQ in Madrid, Spain)	Neuroscience Respiratory Dermatology+2	Commercial	VIEW
296.	Exlixis		-	VIEW
297.	FDC Limited Mumbai, India	Gastroenterology Ophthalmology Cardiovascular+2	Commercial	VIEW
298.	FNCT Biotech Seongnam-si, South Korea	Oncology Immunology	Preclinical	VIEW
299.	Faes Farma Leioa, Spain	Gastroenterology Ophthalmology Dermatology	Phase 3	VIEW
300.	Fapon Dongguan, China	Oncology Immunology Infectious Disease	Preclinical	VIEW
301.	Fate Therapeutics, Inc. San Diego, USA	Oncology	Phase 1	VIEW
302.	FenoMark Diagnostics AB Solna, Sweden	Oncology	Discovery	VIEW
303.	Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil	Infectious Disease Vaccines Rare Diseases+1	Commercial	VIEW
304.	Fishfa Biogenics Rajkot, India	Immunology Infectious Disease Oncology+1	Commercial	VIEW
305.	Flagship Pioneering Cambridge, USA	Oncology Immunology Cardiovascular+2	Discovery	VIEW
306.	Flare Therapeutics Cambridge, MA, USA	Oncology	Phase 1-1B	VIEW
307.	FluGen, Inc. Madison, USA	Infectious Disease	Phase 2	VIEW
308.	Focus Care Pharmaceuticals B.V. Zaandam, Netherlands	Respiratory Neuroscience Cardiovascular+1	Commercial	VIEW
309.	Forma Therapeutics Inc Watertown, USA	Hematology Oncology Rare Diseases	Phase 3	VIEW
310.	Formation Bio New York, USA	Immunology Dermatology Neuroscience	Phase 3	VIEW
311.	Formycon AG Planegg-Martinsried, Germany	Ophthalmology Immunology	Commercial	VIEW
312.	Frontier Medicines South San Francisco, USA	Oncology Immunology	Phase 1/2	VIEW
313.	Fundação Butantan São Paulo, Brazil	Infectious Disease	Phase 2	VIEW
314.	Fusion Pharmaceuticals Inc. Hamilton, Ontario, Canada	Oncology	Phase 1\|Phase 2\|Phase 3	VIEW
315.	G. H. Raisoni University Saikheda, India	Oncology Metabolic Neuroscience+1	Discovery	VIEW
316.	GEN İlaç Ankara, Turkey	Oncology Neuroscience Metabolic+3	Phase 1\|Phase 2\|Commercial	VIEW
317.	GENFIT Loos, France	Metabolic	Phase 2	VIEW
318.	GNT Pharma Yongin, South Korea	Neuroscience Respiratory	Phase 3	VIEW
319.	Galapagos NV Mechelen, Belgium	Immunology Oncology	Phase 2	VIEW
320.	Galpha Laboratories Limited Mumbai, India	Infectious Disease Gastroenterology Dermatology	Commercial	VIEW
321.	Gan & Lee Pharmaceuticals Beijing, China	Metabolic Oncology Cardiovascular	Commercial	VIEW
322.	GenAns Biotech Beijing, China	Neuroscience Ophthalmology Oncology	Preclinical	VIEW
323.	GenLumina Leiden, Netherlands	Oncology	Preclinical	VIEW
324.	Gene Oasis Singapore, Singapore	Oncology Neuroscience Immunology+1	Clinical	VIEW
325.	GeneBiology, Inc. Research Triangle Park, North Carolina, USA	Oncology Neuroscience Gastroenterology	Clinical	VIEW
326.	GeneScience Pharmaceuticals Co., Ltd. (GenSci) Changchun, China	Metabolic Immunology Respiratory+1	Commercial	VIEW
327.	Genentech South San Francisco, California, United States	Oncology Immunology Rare Diseases+3	Discovery through Commercial	VIEW
328.	Genmab Copenhagen, Denmark	Oncology Hematology Immunology	Commercial	VIEW
329.	Gensciences Nantong, China	Hematology	Phase 3	VIEW
330.	George Mason University Fairfax, USA	Oncology Infectious Disease Metabolic+2	Phase 2	VIEW
331.	Georgia Southern University Statesboro, USA	Oncology Infectious Disease Neuroscience+1	Discovery	VIEW
332.	Gesynta Pharma AB Stockholm, Sweden		Phase 2	VIEW
333.	Ghosts Past		-	VIEW
334.	Google (Google DeepMind / Isomorphic Labs) London, United Kingdom	Oncology Immunology Cardiovascular	Preclinical	VIEW
335.	Granite Bio Basel, Switzerland	Immunology	Phase 1	VIEW
336.	Grupo Leti Guarenas, Venezuela	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
337.	Grupo Medifarma, S.A. de C.V. Jiutepec, Mexico	Gastroenterology	Commercial	VIEW
338.	Guangzhou Cellprotek Pharmaceutical Guangzhou, China	Neuroscience Cardiovascular Immunology+1	Phase 3 (Planning)	VIEW
339.	HBM Partners Zug, Switzerland	Oncology Immunology Neuroscience+3	Commercial	VIEW
340.	HCW Biologics Inc. Miramar, Florida, USA	Oncology Immunology	Phase 2	VIEW
341.	HERMES Arzneimittel Holding Pullach im Isartal, Germany		Commercial	VIEW
342.	HERVolution Therapeutics Copenhagen, Denmark	Oncology	Preclinical	VIEW
343.	HGFH (Placeholder Entity) N/A		Discovery	VIEW
344.	HIPRA Amer, Spain		Commercial	VIEW
345.	HLB PEP Co., Ltd. Gwangju, South Korea	Oncology Rare Diseases Immunology	Preclinical	VIEW
346.	HUN-REN Veterinary Medical Research Institute (VMRI) Budapest, Hungary	Infectious Disease	Discovery	VIEW
347.	HUTCHMED Hong Kong	Oncology Immunology Dermatology	Discovery to Phase III	VIEW
348.	Halo Life Science Austin, Texas, United States	Immunology	Discovery	VIEW
349.	Halozyme Therapeutics San Diego, USA	Oncology Immunology Neuroscience+3	Commercial	VIEW
350.	Hamad Bin Khalifa University (HBKU) Doha, Qatar	Oncology Metabolic Infectious Disease+1	Preclinical	VIEW
351.	Hanmi Pharmaceutical Co., Ltd. Seoul, South Korea	Oncology Metabolic Rare Diseases+1	Commercial	VIEW
352.	Hansa Biopharma Lund, Sweden	Immunology Gene Therapy Oncology	Commercial	VIEW
353.	Hansoh Pharmaceutical Group Co., Ltd. Shanghai, China	Oncology Neuroscience Metabolic+1	Phase 3	VIEW
354.	Hanyang University Seoul, South Korea	Oncology Neuroscience Infectious Disease+1	Phase 2	VIEW
355.	Harbour BioMed Shanghai, China	Oncology Immunology Ophthalmology	Phase 3	VIEW
356.	Harmony Biosciences Holdings, Inc. Plymouth Meeting, USA	Neuroscience Rare Diseases	Commercial	VIEW
357.	Healios K.K. Tokyo, Japan	Neuroscience Oncology Ophthalmology	Phase 3	VIEW
358.	Healis Therapeutics Cambridge, USA	Neuroscience	Phase 2/3	VIEW
359.	Health Hope Pharma Hong Kong, Hong Kong	Oncology	Phase 3	VIEW
360.	Hedera Dx Epalinges, Switzerland	Oncology	Commercial	VIEW
361.	Heligenics Phoenix, Arizona, USA	Oncology Rare Diseases	Discovery	VIEW
362.	Hemerion Therapeutics Villeneuve d'Ascq, France	Oncology	Phase 1/2	VIEW
363.	Heranova Lifesciences Burlington, MA, USA		Clinical	VIEW
364.	Hetero Drugs Limited Hyderabad, India	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
365.	Hevolution Foundation Riyadh, Saudi Arabia	Oncology Neuroscience Rare Diseases	Discovery	VIEW
366.	HighQ Technologies Waterloo, Canada		Discovery	VIEW
367.	Highnoon Laboratories Limited Lahore, Pakistan	Cardiovascular Gastroenterology Metabolic+2	Commercial	VIEW
368.	Himont Group Lahore, Pakistan		Commercial	VIEW
369.	Holostem S.r.l. Modena, Italy	Ophthalmology Dermatology Rare Diseases	Commercial	VIEW
370.	Hone Bio Bristol, United Kingdom	Oncology Cardiovascular	Preclinical	VIEW
371.	Hong Kong University of Science and Technology (Guangzhou) Guangzhou, China	Oncology Neuroscience Ophthalmology+1	Phase 2	VIEW
372.	Houston Methodist Houston, USA	Oncology Cardiovascular Neuroscience+1	Discovery	VIEW
373.	Howard University Washington, D.C., USA	Oncology Immunology Cardiovascular	Discovery	VIEW
374.	Huahui Health Ltd. Beijing, China	Oncology	Commercial	VIEW
375.	Hudson Pharmaceuticals Ltd. Dhaka, Bangladesh	Respiratory Ophthalmology Gastroenterology+2	Commercial	VIEW
376.	Humanitas Research Hospital (IRCCS) Rozzano (Milan), Italy	Oncology Immunology Cardiovascular+1	Discovery	VIEW
377.	Humanova Lab Corporation Coral Gables, USA (Registered); Lima, Peru (Operational)		Commercial	VIEW
378.	Humatrix Medical Suzhou, China	Cardiovascular	Preclinical/Early Clinical	VIEW
379.	Huons Co., Ltd. Seongnam, South Korea	Ophthalmology Metabolic	Commercial	VIEW
380.	Hyloris Pharmaceuticals SA Liège, Belgium	Cardiovascular Infectious Disease Oncology+1	Commercial	VIEW
381.	Hyphens Pharma Singapore, Singapore	Dermatology	Commercial	VIEW
382.	IBSA Institut Biochimique SA Lugano, Switzerland	Metabolic Dermatology Respiratory	Commercial	VIEW
383.	IMIDomics, Inc. San Rafael, USA	Immunology Dermatology	Discovery	VIEW
384.	IMTR Inc. Tokyo, Japan	Immunology Hematology Gastroenterology	Phase 1/2	VIEW
385.	IPS Biopharma AG Bern, Switzerland	Oncology Infectious Disease	Phase 2	VIEW
386.	ITESO, Universidad Jesuita de Guadalajara Tlaquepaque, Mexico		Discovery	VIEW
387.	Iasis Pharma Kamatero, Greece	Cardiovascular Dermatology Gastroenterology+3	Commercial	VIEW
388.	Ibn Al-Haytham Pharmaceutical Industries Aleppo, Syria	Cardiovascular	Commercial	VIEW
389.	Idorsia Allschwil, Switzerland	Neuroscience Cardiovascular Immunology+1	Commercial	VIEW
390.	Ignis Therapeutics Shanghai, China	Neuroscience	Phase 3	VIEW
391.	Imexpharm Corporation Cao Lãnh, Vietnam	Cardiovascular Gastroenterology Metabolic+2	Commercial	VIEW
392.	Immorna Biotherapeutics Morrisville, USA	Oncology Infectious Disease Dermatology+1	Phase 2	VIEW
393.	Immune System Key Ltd. (ISK) Jerusalem, Israel	Oncology	Phase 2	VIEW
394.	Immuneel Therapeutics Bengaluru, India	Oncology Hematology Immunology	Commercial	VIEW
395.	Immunethep Cantanhede, Portugal	Infectious Disease Immunology	Preclinical	VIEW
396.	Immunis, Inc. Irvine, California, USA	Immunology	Phase 1/2	VIEW
397.	Immunocore Abingdon, United Kingdom	Oncology Infectious Disease Immunology	Commercial	VIEW
398.	Immunome, Inc. Bothell, Washington, USA	Oncology	Phase 3	VIEW
399.	Immunomic Therapeutics, Inc. Rockville, Maryland, United States	Oncology Infectious Disease	Phase 1 - Phase 2	VIEW
400.	Immunophotonics Saint Louis, Missouri, USA	Oncology Immunology	Phase 2/3	VIEW
401.	Immunovant, Inc. Durham, North Carolina, USA	Immunology Neuroscience Metabolic+1	Phase 3	VIEW
402.	Impact Therapeutics, Inc. Shanghai, China	Oncology	Commercial	VIEW
403.	Incepta Vaccine Ltd. Dhaka, Bangladesh	Infectious Disease	Commercial	VIEW
404.	Incyte Wilmington, Delaware, USA	Oncology Hematology Dermatology+1	Commercial	VIEW
405.	Indian Immunologicals Limited Hyderabad, India	Infectious Disease Immunology	Commercial	VIEW
406.	Indoco Remedies Limited Mumbai, India	Respiratory Cardiovascular	Commercial	VIEW
407.	Industrial Technology Research Institute (ITRI) Hsinchu County, Taiwan		Discovery	VIEW
408.	Infinitopes Oxford, United Kingdom	Oncology	Phase 1/IIa	VIEW
409.	Ingpharm (ООО ИНЖФАРМ) Moscow, Russia		-	VIEW
410.	Initial Therapeutics South San Francisco, USA	Oncology Rare Diseases	Discovery	VIEW
411.	Innovacell Tokyo, Japan	Gastroenterology	Phase 3	VIEW
412.	Innovative Cell Technologies, Inc. San Diego, United States		Commercial	VIEW
413.	Innovent Biologics, Inc. Suzhou, China	Oncology	Commercial	VIEW
414.	Inresa Arzneimittel GmbH Freiburg im Breisgau, Germany	Oncology Infectious Disease	Commercial	VIEW
415.	InsilicoX Co., Ltd. Seoul, South Korea		Discovery	VIEW
416.	Insmed Incorporated Bridgewater, New Jersey, USA	Immunology Rare Diseases	Commercial	VIEW
417.	Institute for Bioengineering of Catalonia (IBEC) Barcelona, Spain	Oncology Neuroscience Rare Diseases+2	Preclinical	VIEW
418.	Institute of Immunology (Imunološki zavod) Zagreb, Croatia	Infectious Disease Immunology	Discovery	VIEW
419.	Instituto Politécnico Nacional (IPN) Mexico City, Mexico	Oncology Rare Diseases Infectious Disease	Discovery	VIEW
420.	Insud Pharma Madrid, Spain	Neuroscience Oncology Cardiovascular+3	Commercial	VIEW
421.	Intas Pharmaceuticals Limited Ahmedabad, India	Oncology Immunology Cardiovascular+2	Commercial	VIEW
422.	Intellia Therapeutics Cambridge, USA	Rare Diseases Cardiovascular Neuroscience+2	Phase 3	VIEW
423.	Intelligene Taipei, Taiwan	Infectious Disease	Phase 1	VIEW
424.	International Centre of Insect Physiology and Ecology (ICIPE) Nairobi, Kenya	Infectious Disease	Discovery\|Preclinical\|Phase 2	VIEW
425.	International Livestock Research Institute (ILRI) Nairobi, Kenya	Infectious Disease	Commercial	VIEW
426.	Interventional AnalgesiX Inc. Durham, North Carolina, United States		Preclinical	VIEW
427.	Intrommune Therapeutics New York, USA	Immunology	Phase 1	VIEW
428.	Inven2 Oslo, Norway	Oncology	Discovery	VIEW
429.	Inventiva Pharma Daix, France	Oncology	Phase 3	VIEW
430.	Ionis Pharmaceuticals, Inc. Carlsbad, USA	Neuroscience Rare Diseases	Commercial	VIEW
431.	Ionis Pharmaceuticals, Inc. Carlsbad, California, United States	Neuroscience Cardiovascular Immunology+1	Phase 1 through Commercial	VIEW
432.	Ironwood Pharmaceuticals Boston, USA	Gastroenterology Rare Diseases	Commercial	VIEW
433.	J-Pharma Co., Ltd. Tokyo, Japan	Oncology Neuroscience Immunology	Phase 3	VIEW
434.	JCR Pharmaceuticals Co., Ltd. Ashiya, Japan	Rare Diseases Neuroscience	Phase 3	VIEW
435.	Janux Therapeutics San Diego, California, USA	Oncology Immunology	Phase 1	VIEW
436.	Japan Institute for Health Security Shinjuku-ku, Tokyo, Japan	Infectious Disease Vaccines	Discovery	VIEW
437.	Jeil Pharmaceutical Co., Ltd. Seoul, South Korea	Oncology Cardiovascular Gastroenterology+2	Phase 2	VIEW
438.	Jiangsu Hengrui Medicine Co., Ltd. Lianyungang, China	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
439.	Jiayue Pharmaceutical Guangzhou, China	Oncology Immunology Infectious Disease	Phase 3	VIEW
440.	Jubilant Therapeutics Bedminster, NJ, United States	Oncology Immunology	Phase I/II Clinical	VIEW
441.	Julphar (Gulf Pharmaceutical Industries) Ras Al Khaimah, United Arab Emirates	Metabolic Gastroenterology Respiratory+4	Commercial	VIEW
442.	Jumpcan Pharmaceutical Taixing, Jiangsu, China	Gastroenterology Respiratory Oncology+1	Commercial	VIEW
443.	Junshi Biosciences Shanghai, China	Oncology Immunology Metabolic+1	Commercial	VIEW
444.	KM Biologics Co., Ltd. Kumamoto, Japan	Infectious Disease Hematology Immunology	Commercial	VIEW
445.	Kailera Therapeutics Waltham, MA, USA	Metabolic	Phase 3	VIEW
446.	KaliVir Immunotherapeutics Pittsburgh, Pennsylvania, USA	Oncology Immunology	Phase 1/1b Clinical	VIEW
447.	Kaohsiung Medical University Kaohsiung, Taiwan	Oncology Infectious Disease	Discovery	VIEW
448.	Kardigan South San Francisco, USA		Phase 2/3	VIEW
449.	Karolinska Institutet Stockholm, Sweden	Oncology Immunology Cardiovascular+1	Discovery	VIEW
450.	Karyon Bio Bengaluru, India (with US presence in Mountain View, California)		Discovery	VIEW
451.	Kedrion Biopharma Barga, Italy	Immunology Hematology Rare Diseases	Commercial	VIEW
452.	Kenai Therapeutics San Diego, USA	Neuroscience	Phase 1	VIEW
453.	Keros Therapeutics Lexington, Massachusetts, United States	Hematology Respiratory Cardiovascular	Phase 1-3	VIEW
454.	Khartis Therapeutics, Inc. San Diego, USA	Immunology	Discovery	VIEW
455.	King Faisal Specialist Hospital and Research Centre (KFSHRC) Riyadh, Saudi Arabia	Oncology Cardiovascular Neuroscience	Clinical	VIEW
456.	Kiniksa Pharmaceuticals London, United Kingdom	Cardiovascular Immunology Rare Diseases	Commercial	VIEW
457.	Kitasato University Tokyo, Japan	Oncology Immunology Neuroscience+1	Discovery	VIEW
458.	Knight Therapeutics Inc. Montreal, Canada	Oncology Hematology Infectious Disease+2	Commercial	VIEW
459.	Kobayashi Pharmaceutical Co., Ltd. Osaka, Japan	Gastroenterology Dermatology	Commercial	VIEW
460.	Korea Regulatory Science Center Seoul, South Korea		-	VIEW
461.	KromaTiD, Inc. Longmont, USA	Oncology Rare Diseases Gene Therapy+1	Discovery	VIEW
462.	Krystal Biotech, Inc. Pittsburgh, USA	Dermatology Respiratory Oncology+1	Commercial	VIEW
463.	Kura Oncology Inc San Diego, California, USA	Oncology	Phase 1\|Phase 2\|Phase 3\|Approved	VIEW
464.	Kymera Therapeutics, Inc. Watertown, Massachusetts, USA	Immunology Oncology	Phase 2	VIEW
465.	Kyung Hee University Seoul, South Korea	Oncology Neuroscience Immunology+1	Phase 3	VIEW
466.	LFB USA Framingham, USA	Immunology	Commercial	VIEW
467.	LG Business Research Seoul, South Korea	Oncology Immunology Vaccines	Commercial	VIEW
468.	Laboratoire Aguettant Lyon, France	Neuroscience	Commercial	VIEW
469.	Laboratorios Bagó Buenos Aires, Argentina	Oncology Hematology Cardiovascular+3	Commercial	VIEW
470.	Laboratorios Lasca (Vicente Scavone y Cía. S.A.E.) San Lorenzo, Paraguay		Commercial	VIEW
471.	Laboratorios Liomont, S.A. de C.V. Ciudad de México, Mexico	Oncology Immunology Infectious Disease+1	Commercial	VIEW
472.	Laboratorios Pharmor SAS Funza, Colombia		Discovery	VIEW
473.	Laboratorios Silanes Mexico City, Mexico	Metabolic Cardiovascular Respiratory+1	Commercial	VIEW
474.	Laboratorios Vita S.A. La Paz, Bolivia	Respiratory	Commercial	VIEW
475.	Laboratorios Viñas Barcelona, Spain	Dermatology	Commercial	VIEW
476.	Ladophar (Lam Dong Pharmaceutical Joint Stock Company) Da Lat, Vietnam		Commercial	VIEW
477.	Lamark Biotech Ahmedabad, India	Oncology	Preclinical	VIEW
478.	Lamyra London, United Kingdom	Dermatology Gastroenterology	Commercial	VIEW
479.	Lantheus Holdings, Inc. Bedford, Massachusetts, USA	Oncology Neuroscience Cardiovascular	Commercial	VIEW
480.	Laurent Pharmaceuticals Montreal, Quebec, Canada		Phase 2/3	VIEW
481.	Legend Biotech Somerset, USA	Oncology Infectious Disease	Commercial	VIEW
482.	Lekli Pharma (LEKLI sh.p.k.) Tirana, Albania	Rare Diseases Neuroscience	Commercial	VIEW
483.	Lepu Biopharma Co., Ltd. Shanghai, China	Oncology	Commercial	VIEW
484.	LiBo Pharma Corp. New Taipei City, Taiwan	Oncology Hematology Immunology	Phase 2/Phase 3	VIEW
485.	Libio Technology Suzhou, China	Cardiovascular Metabolic	Phase 1	VIEW
486.	Lotus Pharmaceutical Co., Ltd. Taipei, Taiwan	Oncology Neuroscience Cardiovascular	Commercial	VIEW
487.	Luminar Life Sciences Lahore, Pakistan		Commercial	VIEW
488.	Luxembourg Institute of Health Strassen, Luxembourg	Oncology Immunology Infectious Disease	Discovery	VIEW
489.	MAB Discovery GmbH Polling, Germany	Oncology Immunology	Preclinical	VIEW
490.	MEPSGEN Seoul, South Korea	Neuroscience Oncology Rare Diseases	Preclinical	VIEW
491.	MS Pharma Amman, Jordan	Cardiovascular Neuroscience Respiratory+1	Commercial	VIEW
492.	MTI Medical (Pvt.) Ltd. Lahore, Pakistan	Metabolic Immunology Oncology+1	Commercial	VIEW
493.	Mahzi Therapeutics South San Francisco, USA	Rare Diseases	Phase 1/2	VIEW
494.	Malaysian Pharmaceutical Industries Sdn. Bhd. Bayan Lepas, Malaysia	Neuroscience Dermatology	Commercial	VIEW
495.	Mariana Oncology (via Carroll Bio Advisory) Watertown, Massachusetts	Oncology	Phase 1	VIEW
496.	Medac GmbH Wedel, Germany	Oncology Hematology Immunology	Commercial/Phase 3	VIEW
497.	MediLink Therapeutics Suzhou, China	Oncology	Phase 2	VIEW
498.	Medical University of Vienna (Medizinische Universität Wien) Vienna, Austria	Oncology Immunology Metabolic+1	Discovery	VIEW
499.	MedinCell Montpellier, France		Commercial\|Phase 3\|Preclinical	VIEW
500.	Medison Pharma Petah Tikva, Israel	Oncology Rare Diseases Immunology+2	Commercial	VIEW